Peer Review History

Original SubmissionMay 7, 2025
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

Decision Letter - Maira Aguiar, Editor, Qu Cheng, Editor

Ecological suitability of Japanese encephalitis virus in Australia: a modelling analysis of vector-host transmission dynamics to potential spillover in humans

PLOS Neglected Tropical Diseases

Dear Dr. Sartorius,

Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 60 days Aug 21 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Maira Aguiar, PhD

Academic Editor

PLOS Neglected Tropical Diseases

Qu Cheng

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

Additional Editor Comments (if provided):

Please revise your manuscript, taking into consideration the reviewers' suggestions. Ensure that all comments are addressed thoroughly and that any changes are clearly indicated in your revised submission.

Journal Requirements:

1) We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type u2018LaTeX Source Fileu2019 and leave your .pdf version as the item type u2018Manuscriptu2019.

2) Please provide an Author Summary. This should appear in your manuscript between the Abstract (if applicable) and the Introduction, and should be 150-200 words long. The aim should be to make your findings accessible to a wide audience that includes both scientists and non-scientists. Sample summaries can be found on our website under Submission Guidelines:

https://journals.plos.org/plosntds/s/submission-guidelines#loc-parts-of-a-submission

3) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: 

https://journals.plos.org/plosntds/s/figures

4) We notice that your supplementary Figures, and Tables are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

5) Some material included in your submission may be copyrighted. According to PLOSu2019s copyright policy, authors who use figures or other material (e.g., graphics, clipart, maps) from another author or copyright holder must demonstrate or obtain permission to publish this material under the Creative Commons Attribution 4.0 International (CC BY 4.0) License used by PLOS journals. Please closely review the details of PLOSu2019s copyright requirements here: PLOS Licenses and Copyright. If you need to request permissions from a copyright holder, you may use PLOS's Copyright Content Permission form.

Please respond directly to this email and provide any known details concerning your material's license terms and permissions required for reuse, even if you have not yet obtained copyright permissions or are unsure of your material's copyright compatibility. Once you have responded and addressed all other outstanding technical requirements, you may resubmit your manuscript within Editorial Manager. 

Potential Copyright Issues:

i) Figure 1 appears to have been previously published. Please provide written permission from the copyright holder to publish this under our CC-BY 4.0 license, or remove the figure / replace the image. Please note we do not recommend using standard request forms available on Publishers' websites, as they grant single use rather than republication under an open access license.

ii) Figures 1, 2, 3, 4, 5, and S3-S6. Please (a) provide a direct link to the base layer of the map (i.e., the country or region border shape) and ensure this is also included in the figure legend; and (b) provide a link to the terms of use / license information for the base layer image or shapefile. We cannot publish proprietary or copyrighted maps (e.g. Google Maps, Mapquest) and the terms of use for your map base layer must be compatible with our CC BY 4.0 license.

Note: if you created the map in a software program like R or ArcGIS, please locate and indicate the source of the basemap shapefile onto which data has been plotted.

If your map was obtained from a copyrighted source please amend the figure so that the base map used is from an openly available source. Alternatively, please provide explicit written permission from the copyright holder granting you the right to publish the material under our CC BY 4.0 license.

If you are unsure whether you can use a map or not, please do reach out and we will be able to help you. The following websites are good examples of where you can source open access or public domain maps:

* U.S. Geological Survey (USGS) - All maps are in the public domain. (http://www.usgs.gov)

* PlaniGlobe - All maps are published under a Creative Commons license so please cite u201cPlaniGlobe, http://www.planiglobe.com, CC BY 2.0u201d in the image credit after the caption. (http://www.planiglobe.com/?lang=enl)

* Natural Earth - All maps are public domain. (http://www.naturalearthdata.com/about/terms-of-use/).

6) We note that your Data Availability Statement is currently as follows: "All relevant data used in this study are clearly referenced with source links to where these data can be accessed.". Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data: 

1) The values behind the means, standard deviations and other measures reported;

2) The values used to build graphs;

3) The points extracted from images for analysis..

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. 

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

7) Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published.

1) State what role the funders took in the study. If the funders had no role in your study, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

2) If any authors received a salary from any of your funders, please state which authors and which funders..

If you did not receive any funding for this study, please simply state: u201cThe authors received no specific funding for this work.u201d

8) Please send a completed 'Competing Interests' statement, including any COIs declared by your co-authors. If you have no competing interests to declare, please state "The authors have declared that no competing interests exist". Otherwise please declare all competing interests beginning with the statement "I have read the journal's policy and the authors of this manuscript have the following competing interests".

Reviewers' Comments:

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The objectives of the study are clearly articulated, focusing on the development of a spatially explicit modelling framework to estimate ecological suitability for Japanese encephalitis virus (JEV) transmission and potential human spillover across Australia. Although a formal hypothesis is not explicitly stated in a traditional sense, the goals are specific, testable, and well defined. The study design is appropriate for addressing these objectives, employing a mechanistic model that integrates ecological, entomological, and human demographic data in a spatial context. The populations under study—specifically the vectors (Cx. annulirostris and Cx. quinquefasciatus), hosts (Ardeidae birds, domestic and feral pigs), and human populations—are well described and relevant for the aims of the analysis.

The sample size, in terms of ecological and occurrence data points, is appropriate for the modelling approach and provides sufficient geographic and taxonomic coverage to ensure robustness. The statistical methods used are appropriate and well justified, including maximum entropy modelling, integration of vector-host contact and competence parameters, and population-weighted validation techniques. These methods adequately support the study's conclusions. No concerns were identified regarding ethical or regulatory compliance, as the study relies solely on publicly available and non-identifiable data, with a clear statement included regarding the role of funding sources and data transparency.

Reviewer #2: - In the construction of any index, it is essential to explicitly state the possible range of values the index can assume, as well as the interpretation of those values. The authors should clarify these aspects for both the ecological suitability index and the human spillover potential index.

- Figure 7 presents the structure used to construct the indices. It is recommended that the main text adopt the same notation as the equations and explicitly demonstrate how the probabilities shown in Figure 7 are derived. While the relevant information is provided in subsections, a direct connection with the formal notation is crucial for clarity and reproducibility.

- In Figure 7, the formulas for each species (VA, VF, and VD) are calculated as the product of probabilities. This implies an assumption of independence between the events of transmission, infection, presence, and bloodfeeding. Is this assumption reasonable? If so, it should be explicitly stated in the text. Moreover, as these components are products of probabilities between 0 and 1, each individual term also ranges from 0 to 1. Consequently, the sum of VA, VF, and VD could range from 0 to 3. Why was equal weighting assigned to each of these components? Do the three features considered (Ardeidae birds, feral pigs, and domestic pigs) indeed contribute equally to vector potential? Additionally, the vector potentials calculated for Culex annulirostris and Culex quinquefasciatus are treated as independent. Is this assumption valid in the ecological context of Australia? If so, this should also be justified in the manuscript. If these interpretations are correct, then the ecological suitability index could range from –3 to 3. In that case, what do high values (either positive or negative) mean? And what about values close to zero? The same line of reasoning applies to the human spillover potential index. If these interpretations are not accurate, the authors should rigorously clarify the actual properties of the presented indicators.

- The interpretation of intermediate values leading to the final indices should be discussed in conjunction with the results shown in Figures 3 and 4. For example, subfigures A) and B) of Figure 3 are not directly comparable, as their color scales have different maximum values: the dark red in A) does not represent the same intensity as in B). This difference should be standardized or justified to allow meaningful comparisons.

- In the legend of Figure 4, the term “vector-host transmission risk” is used. However, the map actually displays the ecological suitability index. It is important to clarify that this index does not directly measure transmission risk, nor is a formal definition of “risk” provided in the manuscript. A similar issue occurs in Table 1. Furthermore, although the values shown on the maps range from 0 to 1, this is not necessarily guaranteed by the model described in Figure 7, and this consistency needs to be revised or justified.

- Finally, the authors should state which software was used for data processing and index construction. It is strongly recommended that all data and code used in the analysis be made publicly available in a suitable repository.

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: The results are clearly and comprehensively presented, and they align well with the stated modelling framework and analysis plan described in the Methods section. The construction and interpretation of the ecological suitability index and the human spillover potential are logically sequenced and directly derived from the described input data, sub-models, and computational procedures. The results offer clear insight into regional variation in risk, supported by quantitative estimates and confidence intervals at national and sub-national levels. Figures and tables are of high quality, with clear legends and sufficient resolution to support interpretation. Spatial maps of host and vector distributions, ecological suitability, and spillover potential are particularly helpful and visually effective. The inclusion of validation results—comparing population-weighted suitability values between affected and unaffected Local Government Areas—adds credibility to the model's predictive utility. Overall, the results are appropriately detailed and well structured, with figures and supplementary materials enhancing the clarity and strength of the findings.

Reviewer #2: (No Response)

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: The conclusions are well supported by the data presented and appropriately reflect the scope and findings of the analysis. The authors clearly describe the limitations of their modelling approach, including the static nature of the estimates, potential biases in ecological niche data, and uncertainties arising from limited empirical data on vector and host species distributions in Australia. These limitations are acknowledged transparently and constructively, with suggestions for future work to incorporate species-level models and temporal dynamics. The discussion effectively places the findings within the broader context of Japanese encephalitis virus emergence, offering clear insights into how this modelling framework advances understanding of ecological drivers and human spillover risk. Importantly, the public health relevance is strongly emphasized, particularly the value of identifying high-risk areas for targeted surveillance, vector control, and vaccination planning. The study provides a useful foundation for proactive interventions and risk mitigation in the face of ongoing environmental change.

Reviewer #2: (No Response)

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Overall, there are relatively minor revisions that, once addressed, will strengthen the manuscript's presentation and accessibility without requiring substantive changes to its analyses or conclusions.

Reviewer #2: (No Response)

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: This manuscript presents a timely and well-executed modelling analysis of Japanese encephalitis virus (JEV) transmission risk and potential human spillover across Australia. By integrating host and vector ecology, vector competence, environmental suitability, and human population distribution into a high-resolution spatial framework, the authors provide a valuable and novel tool for informing public health interventions. The modelling approach is methodologically sound, appropriately validated, and well aligned with the study's stated objectives. The manuscript is clearly written and demonstrates a strong command of ecological modelling and public health relevance. The work is particularly important in the context of recent JEV outbreaks in non-endemic areas of Australia, and it contributes significantly to understanding the drivers of virus emergence and potential persistence.

Strengths of the study include its mechanistic framework, the thoughtful selection of species and ecological inputs, and the clear connection between ecological suitability and real-world public health applications. The limitations are acknowledged transparently and do not detract from the overall value of the findings. There are no concerns regarding research or publication ethics, and all data sources appear appropriately cited and openly accessible. Minor editorial and structural improvements are recommended to improve clarity, but no new experiments or analyses are required. With these revisions, the manuscript will be suitable for publication and will make a strong contribution to the literature on vector-borne disease ecology and preparedness.

Reviewer #2: The article makes a valuable contribution to the understanding of vector-host transmission dynamics and the spillover potential of Japanese encephalitis virus (JEV) in Australia, drawing on methodologies previously established in the literature. The approach adopted incorporates key ecological processes involved in transmission between vectors and hosts, as well as the density and distribution of the human population, to estimate exposure potential. The manuscript is well written, and the results are clearly presented. However, certain conceptual characteristics and properties of the constructed indices need to be more clearly defined and discussed.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions.

Reproducibility:

?>

Attachments
Attachment
Submitted filename: renamed_cd78b.pdf
Revision 1

Attachments
Attachment
Submitted filename: 120825_response_to_reviewers.docx
Decision Letter - Maira Aguiar, Editor, Qu Cheng, Editor

Dear Dr. Sartorius,

We are pleased to inform you that your manuscript 'Ecological suitability of Japanese encephalitis virus in Australia: a modelling analysis of vector-host transmission dynamics to potential spillover in humans' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Maira Aguiar, PhD

Academic Editor

PLOS Neglected Tropical Diseases

Qu Cheng

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

***********************************************************

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 16.0px; font: 14.0px Arial; color: #323333; -webkit-text-stroke: #323333}span.s1 {font-kerning: none

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: (No Response)

Reviewer #2: The authors have adequately addressed the questions and incorporated the requested changes.

The manuscript is well written, and the results are presented clearly.

In this regard, I recommend the publication of the paper.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

Attachments
Attachment
Submitted filename: renamed_ff665.pdf
Formally Accepted
Acceptance Letter - Qu Cheng, Editor

Dear Dr. Sartorius,

We are delighted to inform you that your manuscript, "Ecological suitability of Japanese encephalitis virus in Australia: a modelling analysis of vector-host transmission dynamics to potential spillover in humans," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .